Literature DB >> 8782341

Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs.

M Fekadu1, S L Nesby, J H Shaddock, C L Schumacher, S B Linhart, D W Sanderlin.   

Abstract

A study of immunogenicity and efficacy of Street Alabama Gif (SAG-2) attenuated rabies virus vaccine in laboratory beagles was conducted. Four groups of ten dogs each received either 1.0 ml of SAG-2 orally on the tongue or 1.5 ml in baits. On day 180 postvaccination, all dogs were challenged with a street rabies virus. The antibody response in groups that received the vaccine directly on the tongue was higher than in those vaccinated with baits, but the difference between groups was not statistically significant. All vaccinated dogs survived, whereas 80% of controls died of rabies. Our findings demonstrate that the SAG-2 is a safe and effective vaccine for oral immunization of canines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782341     DOI: 10.1016/0264-410x(95)00244-u

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis.

Authors:  Christophe Préhaud; Stéphanie Lay; Bernhard Dietzschold; Monique Lafon
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease.

Authors:  Bong-Su Kang; Hiroyuki Yahikozawa; Chang-Sung Koh; Byung S Kim
Journal:  Virology       Date:  2007-05-16       Impact factor: 3.616

3.  A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model.

Authors:  Jianqing Zhao; Yijing Zhang; Yixi Chen; Juntao Zhang; Jie Pei; Min Cui; Zhen F Fu; Ling Zhao; Ming Zhou
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

4.  Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs.

Authors:  Ming Zhou; Lei Wang; Songqin Zhou; Zhao Wang; Juncheng Ruan; Lijun Tang; Ziming Jia; Min Cui; Ling Zhao; Zhen F Fu
Journal:  Oncotarget       Date:  2015-11-17

5.  Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.

Authors:  Conrad M Freuling; Verena Te Kamp; Antonia Klein; Maria Günther; Luca Zaeck; Madlin Potratz; Elisa Eggerbauer; Katharina Bobe; Christian Kaiser; Antje Kretzschmar; Steffen Ortmann; Peter Schuster; Adriaan Vos; Stefan Finke; Thomas Müller
Journal:  Viruses       Date:  2019-08-27       Impact factor: 5.048

6.  Responsiveness of various reservoir species to oral rabies vaccination correlates with differences in vaccine uptake of mucosa associated lymphoid tissues.

Authors:  Verena Te Kamp; Conrad M Freuling; Ad Vos; Peter Schuster; Christian Kaiser; Steffen Ortmann; Antje Kretzschmar; Sabine Nemitz; Elisa Eggerbauer; Reiner Ulrich; Jan Schinköthe; Tobias Nolden; Thomas Müller; Stefan Finke
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

7.  Development in Immunoprophylaxis against Rabies for Animals and Humans.

Authors:  Sukdeb Nandi; Manoj Kumar
Journal:  Avicenna J Med Biotechnol       Date:  2010-01

Review 8.  Oral vaccination of dogs: a well-studied and undervalued tool for achieving human and dog rabies elimination.

Authors:  Florence Cliquet; Anne-Laure Guiot; Michel Aubert; Emmanuelle Robardet; Charles E Rupprecht; François-Xavier Meslin
Journal:  Vet Res       Date:  2018-07-13       Impact factor: 3.683

9.  Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife.

Authors:  Susan M Moore; Amy Gilbert; Ad Vos; Conrad M Freuling; Christine Ellis; Jeannette Kliemt; Thomas Müller
Journal:  Trop Med Infect Dis       Date:  2017-07-21

Review 10.  Review of Oral Rabies Vaccination of Dogs and Its Application in India.

Authors:  Gowri Yale; Marwin Lopes; Shrikrishna Isloor; Jennifer R Head; Stella Mazeri; Luke Gamble; Kinzang Dukpa; Gyanendra Gongal; Andrew D Gibson
Journal:  Viruses       Date:  2022-01-14       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.